PBSV (Pharma-Bio Serv) 1-Year Sharpe Ratio : -1.04 (As of Jun. 28, 2025)

View and export this data going back to 2006. Start your Free Trial

What is Pharma-Bio Serv 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-06-28), Pharma-Bio Serv's 1-Year Sharpe Ratio is -1.04.

Competitive Comparison of Pharma-Bio Serv's 1-Year Sharpe Ratio

For the Health Information Services subindustry, Pharma-Bio Serv's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma-Bio Serv's 1-Year Sharpe Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Pharma-Bio Serv's 1-Year Sharpe Ratio falls into.

Save Embed

;

Save Embed

;

Pharma-Bio Serv 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Pharma-Bio Serv (OTCPK:PBSV) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Pharma-Bio Serv 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Pharma-Bio Serv's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma-Bio Serv Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharma-Bio Serv Inc (OTCPK:PBSV) » Definitions » 1-Year Sharpe Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646

Website

https://www.pharmabioserv.com

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.

Executives

Elizabeth Plaza	10 percent owner	363 DORADO BEACH EAST, DORADO PR 00646
Altura Victor Sanchez	officer: President and CEO	C/O PHARMA-BIO SERV, INC., 6 ROAD 696, DORADO PR 00646
San Juan Holdings	10 percent owner	255 PONCE DE LEON, SUITE 305 MCS PLAZA, SAN JUAN PR 00917
Pedro J Lasanta	officer: Chief Financial Officer	373 MENDEZ VIGO, STE 110, DORADO PR 00646
Dov Perlysky	director	2 LAKESIDE DRIVE WEST, LAWRENCE NY 11559
L P Venturetek	10 percent owner	C/O DAVID SELENGUT ELLENOFF GROSSMAN, 370 LEXINGTON AVENUE 19TH FLOOR, NEW YORK NY 10017
Barron Partners Lp	10 percent owner	730 FIFTH AVENUE, 25TH FLOOR, NEW YORK NY 10019
Manuel O Morera	officer: Chief Financial Officer	373 MENDEZ VIGO, SUITE 110, DORADO PR 00646
Mark A Fazio	officer: Exec. Vice President and COO	P O BOX 1026 GREEN STREET, PERKASIE PA 18944
Kirk Wheeler Michel	director	209 EAST TRYON STREET, HILLSBOROUGH NC 27278
Irving L Wiesen	director	1273 NORTH AVENUE, APT 1E 7, NEW ROCHELLE NY 10804
Howard Spindel	director	39 BROADWAY SUITE 3300, NEW YORK NY 10028
Nelida Plaza Rodriguez	officer: Vice President and Secretary	G11 CALLE MADRE PERLA URB, DORADO DEL MAR, DORADO PR 00646
Krovim Llc	director, 10 percent owner, officer: Manager	P.O. BOX 339, LAWRENCE NY 11559